Live data from Hacker News

Viewing profile — chrisprobert

chrisprobert

HN member
Joined
Tue, Oct 07, 2014, 9:04 PM UTC
HN karma
88
Public activity
25 items

About chrisprobert

http://chrisprobert.com

Recent public activity

  1. story
  2. story
  3. story
  4. comment
    Comment #18810591

    insitro | Machine Learning for Drug Discovery | South San Francisco, CA | Full Time | Onsite insitro is reinventing drug discovery by bringing cutting-edge machine learning in a cl…

  5. story
  6. comment
    Comment #17402459

    I'm curious whether this is backed by Google File System ( https://static.googleusercontent.com/media/research.google.c... ), or something else.

  7. comment
    Comment #17230110

    What's interesting about this approach (TIL expansion) relative to other leading cellular immunotherapy approaches (CAR-T/NK and TCR) is that it doesn't rely on gene editing. Long …

  8. comment
    Comment #16580345

    Coupa Cafe on Ramona St. in Palo Alto, or the one in Y2E2 at Stanford.

  9. comment
    Comment #15596455

    Totally agree!

  10. comment
    Comment #15595710

    Announcing TensorFlow's new development roadmap mandate: copy everything PyTorch is doing :-)

  11. comment
    Comment #15480272

    Great to see this coming from a team with such a solid AI background!

  12. story
  13. story
  14. story
    Apply HN: Artisanal Genomics

    Problem: Modern genomics is a commoditized science. Technologies like low-cost DNA sequencing, CRISPR DNA editing, and microarrays mean progress is happening too fast. Solution: Br…

  15. comment
    Comment #10672155

    I would put > 50/50 odds on there being a human alive today with at least one CRISPR-edited germline variant. I think the question is now how can we regulate/control CRISPR germlin…

  16. story
  17. comment
    Comment #10597310

    Key question for digital health / biotech startups is whether direct to consumer (D2C) advertising for testing services (e.g. genetic carrier screening; cancer risk screening) woul…

  18. comment
    Comment #10402612

    Correct - their current v4 chip covers ~602K SNPs and they have > 1 M customers, so you couldn't uniquely identify all of them by genotype. But given the frequency of rare variatio…

  19. comment
    Comment #10402349

    You're right that Ancestry.com is focused on mtDNA, but 23andMe actually uses a custom Illumina microarray with autosome, allosome, and mitochondrial targets. Here's a study where …

  20. story
  21. comment
    Comment #10370313

    Totally agree here - would be easy to fabricate DNA oligos with given mtDNA or STR sequences, especially if you know forensic investigators are only going to use very small target …

  22. comment
    Comment #10367187

    Good question. This problem affects multiple steps of a NGS-based forensics product: sample collection, DNA extraction, library preparation, the sequencing itself, alignment/assemb…

  23. comment
    Comment #10366974

    This article brings up problems with current PCR-based STR genotyping methods, but lacks information about technologies that are competing to be the future of forensic genotyping. …

  24. story
  25. comment
    Comment #8438465

    I also enjoyed his post on the "Two Cultures of Computing": http://pgbovine.net/two-cultures-of-computing.htm Definitely something worth thinking about as we build tools for other …